Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 42001-42050 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05950893
The Clinical Feasibility and Validity of PMIvent to Access Inspiratory Effort During Pressure Support Ventilation
NARecruiting
25 participants
Started: Mar 25, 2023 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT06093737
Strengthening Community Mental Health
NARecruiting
300 participants
Started: Mar 25, 2023 · Completed: Jun 30, 2025
8 conditions3 sponsors1 location
NCT05783869
Study of Bronchiectasis and Associated Cardiovascular Comorbidities
N/ARecruiting
30 participants
Started: Mar 25, 2023 · Completed: Nov 1, 2026
1 condition2 sponsors1 location
NCT05811273
Effect of Physical Readiness Training In Badminton Players
NARecruiting
24 participants
Started: Mar 25, 2023 · Completed: Jun 22, 2024
1 condition1 sponsor1 location
NCT05842148
Quality of Life After Conservative Oncoplastic Surgery in Breast Cancer Patients (IRONY: lIfe afteR ONcoplastic surgerY)
N/ARecruiting
250 participants
Started: Mar 25, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05778981
Endothelial Dysfunction and Non-cardiac Surgery
N/ARecruiting
200 participants
Started: Mar 25, 2023 · Completed: Dec 1, 2025
4 conditions2 sponsors1 location
NCT06036875
CARE: Cancer Risk Perception and Women of Color
N/ARecruiting
550 participants
Started: Mar 25, 2023 · Completed: Feb 23, 2028
1 condition1 sponsor3 locations
NCT05842928
Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderly Patients With Polypharmacy
NARecruiting
352 participants
Started: Mar 25, 2023 · Completed: Oct 31, 2026
6 conditions8 sponsors3 locations
NCT06077617
Bedside Ultrasound Assessment of Feeding Tube Position in the Intensive Care Unit
N/ARecruiting
423 participants
Started: Mar 24, 2023 · Completed: Jul 16, 2025
2 conditions1 sponsor1 location
NCT05766254
Identify the Optimal TMS Target to Modulate Reward Activity
NARecruiting
36 participants
Started: Mar 24, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05524428
Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
NARecruiting
2 participants
Started: Mar 24, 2023 · Completed: Dec 31, 2024
1 condition2 sponsors4 locations
NCT05801276
ctDNA Methylation for Detecting Ovarian Cancer
N/ARecruiting
1,400 participants
Started: Mar 24, 2023 · Completed: Mar 24, 2026
9 conditions1 sponsor1 location
NCT05892900
Transcutaneous Vagus Nerve Stimulation (tVNS) for Borderline Personality Disorder (tVNS-BPD)
NARecruiting
42 participants
Started: Mar 24, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05239546
Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers
PHASE2Recruiting
25 participants
Started: Mar 24, 2023 · Completed: Jun 30, 2029
2 conditions1 sponsor1 location
NCT05827614
Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications
PHASE1Recruiting
127 participants
Started: Mar 24, 2023 · Completed: Mar 31, 2027
12 conditions1 sponsor17 locations
NCT05625659
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
NARecruiting
2,032 participants
Started: Mar 24, 2023 · Completed: Jan 1, 2027
1 condition3 sponsors10 locations
NCT05772455
A Study of XZB-0004 in Patients With Solid Tumors
PHASE1Recruiting
128 participants
Started: Mar 24, 2023 · Completed: Feb 28, 2027
2 conditions1 sponsor1 location
NCT05742074
The Effect of Faecal Microbiota Transplantation (FMT) on Eradication of Multidrug Resistant Organisms (MRO) in Intestinal Carriers
NARecruiting
80 participants
Started: Mar 24, 2023 · Completed: Nov 30, 2028
2 conditions4 sponsors1 location
NCT05617963
Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the Thorax
PHASE2Recruiting
100 participants
Started: Mar 24, 2023 · Completed: Feb 24, 2030
1 condition2 sponsors32 locations
NCT05801861
Modulating Goal-directed Navigation Using Noninvasive Brain Stimulation
NARecruiting
60 participants
Started: Mar 24, 2023 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05689645
F573 for Injection for the Treatment of Liver Injury/Failure
PHASE2Recruiting
97 participants
Started: Mar 24, 2023 · Completed: Mar 31, 2026
2 conditions1 sponsor10 locations
NCT05545501
Ketone Ester and Acute Salt (KEAS) in Young Adults
NARecruiting
35 participants
Started: Mar 24, 2023 · Completed: Sep 30, 2026
2 conditions4 sponsors1 location
NCT05835999
Everolimus Aging Study
PHASE2Recruiting
88 participants
Started: Mar 24, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT07119710
Telehealth to Improve Quality of Life in Persons Living in Rural Texas
NARecruiting
60 participants
Started: Mar 24, 2023 · Completed: Dec 1, 2028
2 conditions1 sponsor1 location
NCT05411081
Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial
PHASE2Recruiting
200 participants
Started: Mar 24, 2023 · Completed: Jul 1, 2027
2 conditions1 sponsor200 locations
NCT06622759
The Use of a Porcine Collagen Matrix for the Prevention of Buccal Bone Wall Resorption During Implant Placement in the Aesthetic Zone.
PHASE2Recruiting
36 participants
Started: Mar 24, 2023 · Completed: Aug 30, 2025
1 condition1 sponsor1 location
NCT06586593
Neoadjuvant Immunotherapy of Operable Metastatic Melanoma in Real Life (GCC)
N/ARecruiting
77 participants
Started: Mar 24, 2023 · Completed: Jan 31, 2025
1 condition1 sponsor9 locations
NCT05175300
Interest of a Highly Cross-linked Polyethylene Acetabular Component Doped With Vitamin E in Total Hip Arthroplasty of the Young and Active Subject
NARecruiting
100 participants
Started: Mar 24, 2023 · Completed: Mar 31, 2030
1 condition1 sponsor1 location
NCT05610085
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
PHASE2Recruiting
133 participants
Started: Mar 24, 2023 · Completed: Dec 31, 2027
4 conditions6 sponsors4 locations
NCT05513872
Overcoming Nicotine Dependence to Enable Quitting
PHASE1/PHASE2Recruiting
780 participants
Started: Mar 24, 2023 · Completed: Aug 30, 2027
5 conditions2 sponsors1 location
NCT05083247
Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma
PHASE2Recruiting
256 participants
Started: Mar 24, 2023 · Completed: Dec 31, 2030
3 conditions4 sponsors10 locations
NCT05549752
Flecainide Versus Amiodarone in the Cardioversion of Paroxysmal Atrial Fibrillation at the Emergency Department, in Patients With Coronary Artery Disease Without Residual Ischemia
PHASE3Recruiting
80 participants
Started: Mar 24, 2023 · Completed: Jan 30, 2026
2 conditions3 sponsors3 locations
NCT05765370
LDL Cholesterol TARGETs in OLDer Patients (Age≥75 Years) With ASCVD (TARGET OLD)
NARecruiting
4,200 participants
Started: Mar 24, 2023 · Completed: Dec 24, 2026
3 conditions1 sponsor1 location
NCT05801263
ctDNA Methylation for Epithelial Ovarian Cancer
N/ARecruiting
5,000 participants
Started: Mar 24, 2023 · Completed: Mar 24, 2026
8 conditions1 sponsor1 location
NCT06086574
Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung Cancer
N/ARecruiting
80 participants
Started: Mar 24, 2023 · Completed: Sep 24, 2025
1 condition2 sponsors1 location
NCT06367920
Multicenter Study on Rehabilitation Medical Data for Pediatric Big Brain Development
N/ARecruiting
2,000 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05389774
DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction Solution
N/ARecruiting
2,000 participants
Started: Mar 23, 2023 · Completed: Aug 31, 2025
4 conditions2 sponsors10 locations
NCT05616273
Stimulated Glucagon As a Biomarker of Hypoglycemic Risk in Type 1 Diabetes
N/ARecruiting
75 participants
Started: Mar 23, 2023 · Completed: Sep 30, 2025
2 conditions2 sponsors1 location
NCT06380387
Whole Body Metabolism in Children Before and After Treatment of CNS Tumor
NARecruiting
30 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05848570
Keeping it LITE: Exploring HIV Risk in Vulnerable Youth With Limited Interaction and Digital Health Intervention
N/ARecruiting
6,000 participants
Started: Mar 23, 2023 · Completed: May 31, 2027
2 conditions2 sponsors1 location
NCT05416060
Dulce Digital 2.0 - Innovative Diabetes Self-Management in the Digital Age
NARecruiting
150 participants
Started: Mar 23, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor2 locations
NCT06135597
Immune Regulation in Chronic Aspergillus Infection After COVID-19 Infection
N/ARecruiting
100 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06673875
Assessment of Pelvic Floor Muscle Training Using Modern Conservative Methods in the Therapy of Stress Urinary Incontinence
NARecruiting
90 participants
Started: Mar 23, 2023 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT05817929
Angiopoietin and Adverse Outcomes in Cardiac Surgery
NARecruiting
200 participants
Started: Mar 23, 2023 · Completed: Apr 30, 2027
2 conditions1 sponsor1 location
NCT05669430
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
PHASE1/PHASE2Recruiting
365 participants
Started: Mar 23, 2023 · Completed: Sep 5, 2027
7 conditions2 sponsors13 locations
NCT05837260
Investigating Utility of ctDNA and Tumour Evolution in Advanced Thyroid Cancer
N/ARecruiting
120 participants
Started: Mar 23, 2023 · Completed: Feb 7, 2027
1 condition1 sponsor1 location
NCT05689879
Evaluation of TNF-alpha Antagonists (Infliximab) Withdrawal in Sarcoidosis
PHASE3Recruiting
90 participants
Started: Mar 23, 2023 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT06187012
Hypertension Explored in Long-term Postpartum Follow-up in Later Life
N/ARecruiting
200 participants
Started: Mar 23, 2023 · Completed: Nov 1, 2042
4 conditions1 sponsor1 location
NCT05780307
IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors
PHASE1Recruiting
48 participants
Started: Mar 23, 2023 · Completed: Oct 26, 2025
6 conditions2 sponsors1 location
NCT05725720
Role of the Gut Microbiome in the Outcome of Diffuse Large B-Cell Lymphoma Patients Treated With CAR-T Cell Therapy
N/ARecruiting
90 participants
Started: Mar 23, 2023 · Completed: Dec 31, 2027
1 condition3 sponsors1 location